Risk factors for intellectual disability in children with spastic cerebral palsy.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
10 2021
Historique:
received: 10 08 2020
revised: 11 01 2021
accepted: 23 01 2021
pubmed: 18 3 2021
medline: 23 11 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

Cerebral palsy (CP) is a non-progressive disorder of posture and movement caused by prenatal or perinatal lesions of the brain. Children with CP are also at increased risk of other disabilities, for example, intellectual disability. Previous studies suggest the risk of intellectual disability varies in complex ways according to the type of motor impairment and perinatal factors such as gestational age. To determine the patterns of risk of intellectual disability in children with spastic CP. Cross-sectional, population-based study using the Northern Ireland Cerebral Palsy Register. Persons born in 1981-2008 with congenital bilateral or unilateral spastic CP (N=1452). The outcome measure was severe intellectual disability (IQ <50), as reported by clinicians known to the child. Data pertaining to CP subtype, sex, gestational age, birth weight and functional level were included in analyses. Severe intellectual disability was significantly more prevalent in children with bilateral spastic CP (BSCP) compared with children with unilateral spastic CP (χ² (2)=162.60, p<0.001). Compared with very preterm infants with BSCP, the risk of intellectual disability increased in moderately preterm (OR=3.97, 95% CI 1.04 to 15.23) and at-term (OR=2.51, 95% CI 1.16 to 5.44) children with BSCP. Children with BSCP are at increased risk of intellectual disability, with those born at term at the highest risk. The findings highlight the importance of early screening, particularly for children with BSCP born at term.

Sections du résumé

BACKGROUND
Cerebral palsy (CP) is a non-progressive disorder of posture and movement caused by prenatal or perinatal lesions of the brain. Children with CP are also at increased risk of other disabilities, for example, intellectual disability. Previous studies suggest the risk of intellectual disability varies in complex ways according to the type of motor impairment and perinatal factors such as gestational age.
OBJECTIVE
To determine the patterns of risk of intellectual disability in children with spastic CP.
DESIGN
Cross-sectional, population-based study using the Northern Ireland Cerebral Palsy Register.
PARTICIPANTS
Persons born in 1981-2008 with congenital bilateral or unilateral spastic CP (N=1452).
OUTCOME MEASURE
The outcome measure was severe intellectual disability (IQ <50), as reported by clinicians known to the child. Data pertaining to CP subtype, sex, gestational age, birth weight and functional level were included in analyses.
RESULTS
Severe intellectual disability was significantly more prevalent in children with bilateral spastic CP (BSCP) compared with children with unilateral spastic CP (χ² (2)=162.60, p<0.001). Compared with very preterm infants with BSCP, the risk of intellectual disability increased in moderately preterm (OR=3.97, 95% CI 1.04 to 15.23) and at-term (OR=2.51, 95% CI 1.16 to 5.44) children with BSCP.
CONCLUSIONS
Children with BSCP are at increased risk of intellectual disability, with those born at term at the highest risk. The findings highlight the importance of early screening, particularly for children with BSCP born at term.

Identifiants

pubmed: 33727240
pii: archdischild-2020-320441
doi: 10.1136/archdischild-2020-320441
pmc: PMC8461399
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

975-980

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CK and KM have received research funding from the Medical Research Council Proximity to Discovery Scheme supporting academic–industry collaboration.

Références

Am J Obstet Gynecol. 2017 Aug;217(2):167-175
pubmed: 28427805
Pediatrics. 2016 Nov;138(5):
pubmed: 27940782
Dev Med Child Neurol. 2016 Jan;58(1):85-92
pubmed: 26330098
Twin Res Hum Genet. 2006 Jun;9(3):460-6
pubmed: 16790158
Ann Epidemiol. 2016 Mar;26(3):222-6
pubmed: 26851824
Dev Med Child Neurol. 2006 Jun;48(6):417-23
pubmed: 16700930
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Res Dev Disabil. 2016 Sep;56:83-98
pubmed: 27262445
Dev Med Child Neurol. 2020 Mar;62(3):283-289
pubmed: 32010976
Eur J Epidemiol. 2020 Mar;35(3):273-282
pubmed: 31788734
Am J Perinatol. 2013 Apr;30(4):335-41
pubmed: 22893556
Clin Obstet Gynecol. 2008 Dec;51(4):816-28
pubmed: 18981805
Dev Med Child Neurol. 2018 Jul;60(7):687-694
pubmed: 29667705
Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F208-14
pubmed: 10794788
Dev Neurorehabil. 2018 Feb;21(2):108-120
pubmed: 28632466
Dev Med Child Neurol. 2000 Dec;42(12):816-24
pubmed: 11132255
Dev Med Child Neurol Suppl. 2007 Feb;109:8-14
pubmed: 17370477
Arch Phys Med Rehabil. 2012 Mar;93(3):480-4
pubmed: 22265344
Trends Cogn Sci. 2005 Mar;9(3):104-10
pubmed: 15737818
Am J Obstet Gynecol. 2012 Feb;206(2):173.e1-8
pubmed: 22055336
Dev Med Child Neurol. 2018 Oct;60(10):1026-1032
pubmed: 29726578
Dev Med Child Neurol. 2008 May;50(5):357-62
pubmed: 18355334
J Pediatr. 1993 Oct;123(4):618-24
pubmed: 7692029
Dev Med Child Neurol. 1997 Apr;39(4):214-23
pubmed: 9183258
Neuropediatrics. 2020 Apr;51(2):113-119
pubmed: 32120429
Ann Epidemiol. 2016 Apr;26(4):267-74
pubmed: 27085382
Neuropediatrics. 2020 Apr;51(2):120-128
pubmed: 32120428
Dev Med Child Neurol. 2014 Apr;56(4):361-9
pubmed: 24116829
Noro Psikiyatr Ars. 2017 Mar;54(1):33-37
pubmed: 28566956
Dev Med Child Neurol. 2006 Jun;48(6):406-12; discussion 405
pubmed: 16700928
J Pediatr. 2008 Aug;153(2):203-8, 208.e1-4
pubmed: 18534232
Am Psychol. 1995 Feb;50(2):79-95
pubmed: 7879990

Auteurs

David Cummins (D)

Royal Jubilee Maternity Service, Belfast, UK.

Claire Kerr (C)

School of Nursing and Midwifery, Queen's University Belfast, Belfast, UK c.kerr@qub.ac.uk.

Karen McConnell (K)

School of Nursing and Midwifery, Queen's University Belfast, Belfast, UK.

Oliver Perra (O)

School of Nursing and Midwifery, Queen's University Belfast, Belfast, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH